These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694 [TBL] [Abstract][Full Text] [Related]
4. Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. Bergman BC; Cornier MA; Horton TJ; Bessesen DH Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1103-11. PubMed ID: 17684102 [TBL] [Abstract][Full Text] [Related]
5. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626 [TBL] [Abstract][Full Text] [Related]
6. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Jessen N; Djurhuus CB; Jørgensen JO; Jensen LS; Møller N; Lund S; Schmitz O Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E194-9. PubMed ID: 15339744 [TBL] [Abstract][Full Text] [Related]
7. Regulation of skeletal muscle energy/nutrient-sensing pathways during metabolic adaptation to fasting in healthy humans. Wijngaarden MA; Bakker LE; van der Zon GC; 't Hoen PA; van Dijk KW; Jazet IM; Pijl H; Guigas B Am J Physiol Endocrinol Metab; 2014 Nov; 307(10):E885-95. PubMed ID: 25249505 [TBL] [Abstract][Full Text] [Related]
8. Muscle acylcarnitines during short-term fasting in lean healthy men. Soeters MR; Sauerwein HP; Duran M; Wanders RJ; Ackermans MT; Fliers E; Houten SM; Serlie MJ Clin Sci (Lond); 2009 Apr; 116(7):585-92. PubMed ID: 18945215 [TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance. Serlie MJ; Allick G; Groener JE; Ackermans MT; Heijligenberg R; Voermans BC; Aerts JM; Meijer AJ; Sauerwein HP J Clin Endocrinol Metab; 2007 Jan; 92(1):166-71. PubMed ID: 17062758 [TBL] [Abstract][Full Text] [Related]
11. Decreased insulin action in skeletal muscle from patients with McArdle's disease. Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356 [TBL] [Abstract][Full Text] [Related]
12. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids. Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017 [TBL] [Abstract][Full Text] [Related]
13. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo. Park E; Wong V; Guan X; Oprescu AI; Giacca A J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543 [TBL] [Abstract][Full Text] [Related]
14. Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells. Ghosh N; Patel N; Jiang K; Watson JE; Cheng J; Chalfant CE; Cooper DR Endocrinology; 2007 Mar; 148(3):1359-66. PubMed ID: 17158207 [TBL] [Abstract][Full Text] [Related]
15. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. Serlie MJ; Meijer AJ; Groener JE; Duran M; Endert E; Fliers E; Aerts JM; Sauerwein HP J Clin Endocrinol Metab; 2007 Apr; 92(4):1524-9. PubMed ID: 17264178 [TBL] [Abstract][Full Text] [Related]
16. Effects of insulin on ketogenesis following fasting in lean and obese men. Soeters MR; Sauerwein HP; Faas L; Smeenge M; Duran M; Wanders RJ; Ruiter AF; Ackermans MT; Fliers E; Houten SM; Serlie MJ Obesity (Silver Spring); 2009 Jul; 17(7):1326-31. PubMed ID: 19369940 [TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle ceramides do not contribute to physical-inactivity-induced insulin resistance. Appriou Z; Nay K; Pierre N; Saligaut D; Lefeuvre-Orfila L; Martin B; Cavey T; Ropert M; Loréal O; Rannou-Bekono F; Derbré F Appl Physiol Nutr Metab; 2019 Nov; 44(11):1180-1188. PubMed ID: 30889368 [TBL] [Abstract][Full Text] [Related]
18. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. Krusenstjerna-Hafstrøm T; Clasen BF; Møller N; Jessen N; Pedersen SB; Christiansen JS; Jørgensen JO J Clin Endocrinol Metab; 2011 Aug; 96(8):2548-57. PubMed ID: 21613350 [TBL] [Abstract][Full Text] [Related]
20. Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Frøsig C; Rose AJ; Treebak JT; Kiens B; Richter EA; Wojtaszewski JF Diabetes; 2007 Aug; 56(8):2093-102. PubMed ID: 17513702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]